Tania Schink

Bremen, HB, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Prevalence, psychiatric comorbidity and treatment of multiple personality disorder in Germany: an analysis based on nationwide claims data, 2012-2021.

Prevalence, psychiatric comorbidity and treatment of multiple personality disorder in Germany: an analysis based on nationwide claims data, 2012-2021.

Journal: European journal of psychotraumatology

Published: March 24, 2026

Vaccinations during pregnancy in Germany between 2004 and 2022: a claims data analysis.

Vaccinations during pregnancy in Germany between 2004 and 2022: a claims data analysis.

Journal: Scientific reports

Published: January 22, 2026

Use of Carbimazole, Methimazole and Propylthiouracil in Women of Childbearing Age and Exposed Pregnancies in Germany: A Population-Based Study.

Use of Carbimazole, Methimazole and Propylthiouracil in Women of Childbearing Age and Exposed Pregnancies in Germany: A Population-Based Study.

Journal: Drugs - real world outcomes

Published: November 06, 2025

Postnatal and long-term outcomes after in utero exposure to RAAS inhibitors: cohort study based on German claims data.

Postnatal and long-term outcomes after in utero exposure to RAAS inhibitors: cohort study based on German claims data.

Journal: Pediatric nephrology (Berlin, Germany)

Published: June 13, 2025

Lithium Use During Pregnancy in 14 Countries.

Lithium Use During Pregnancy in 14 Countries.

Journal: JAMA network open

Published: December 16, 2024

A discovery and verification approach to pharmacovigilance using electronic healthcare data.

A discovery and verification approach to pharmacovigilance using electronic healthcare data.

Journal: Frontiers in pharmacology

Published: May 01, 2024

Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study.

Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study.

Journal: International journal of chronic obstructive pulmonary disease

Published: April 05, 2024

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.

Journal: BMJ open

Published: March 26, 2024

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

Journal: PloS one

Published: July 05, 2023

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.

Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.

Journal: Expert opinion on drug safety

Published: February 16, 2023

Authors' reply.

Authors' reply.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: February 09, 2023

In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study.

In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: December 18, 2022

Showing 1-12 of 74

Last Updated: 09/26/2026